Peptide solubility and reconstitution

Whether a lyophilised peptide dissolves cleanly at the concentration an assay needs follows from its sequence: net charge at the working pH, the fraction of hydrophobic residues, chain length and any lipid modification. This article sets out that chemistry, a way to predict solubility from a sequence, and how research peptides are reconstituted at the bench. NuVion Health supplies synthetic research peptides as laboratory chemicals for in vitro research use only.

What solubility means for a peptide

Solubility is the equilibrium concentration of dissolved peptide in a given solvent at a given temperature and pH, reported in mg/mL or mol/L. A lyophilised research peptide is a salt, usually the trifluoroacetate, so what goes into solution is the peptide with its counter-ions and residual water. And a peptide can dissolve and then self-associate into soluble oligomers, so a clear solution is not proof of a monomeric one; dynamic light scattering shows whether that has happened.

Charge and the isoelectric point

Charge is the largest single factor. At neutral pH the N-terminal amine, lysine and arginine carry positive charge; the C-terminal carboxyl, aspartate and glutamate carry negative charge; histidine, with a side-chain pKa near 6, is partly protonated. A quick net charge estimate at pH 7 is the count of lysine and arginine residues plus one for a free N-terminus, minus the count of aspartate and glutamate residues, minus one for a free C-terminal acid. A C-terminal amide, as in oxytocin, removes that last negative charge, and an N-terminal acetyl group removes the positive one.

The pH at which the charges cancel is the isoelectric point, pI. Solubility is lowest there because electrostatic repulsion between chains disappears. Working at least one pH unit away from the pI keeps a net charge on every chain. A peptide with a net positive charge dissolves in water or in dilute acetic acid, a peptide with a net negative charge dissolves in water or dilute ammonium bicarbonate, and a peptide with a net charge near zero is the one most likely to need an organic co-solvent.

Hydrophobicity and aggregation

Alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan and tyrosine drive self-association in water. A sequence in which more than about half the residues are hydrophobic, or that contains a run of five or more of them, tends to dissolve poorly in water regardless of charge. Chains of alternating hydrophobic and polar residues can line up into beta-sheet aggregates, which appear as a haze or a gel over hours. Lipidated peptides behave like surfactants. Tirzepatide carries a C20 diacid on a lysine side chain and forms micelle-like assemblies above a critical concentration, which is expected and distinct from irreversible aggregation.

A free cysteine thiol oxidises to a disulfide-linked dimer in air, faster at basic pH, so cysteine-containing peptides are dissolved in slightly acidic, degassed solvent.

Solvents used in the laboratory

• Bacteriostatic water: sterile water containing 0.9% benzyl alcohol, the standard solvent for reconstituting a research peptide. The benzyl alcohol limits microbial growth once the vial has been opened.
• Dilute acetic acid for basic peptides that dissolve slowly in water, diluted into assay buffer afterwards.
• Dilute ammonium bicarbonate for acidic peptides, avoided with cysteine, methionine or tryptophan sequences because base accelerates their oxidation.
• Dimethyl sulfoxide (DMSO) for hydrophobic peptides, added first to wet the powder and then diluted with water or buffer. Cell assays usually tolerate a final DMSO concentration of 0.1 to 0.5%.
• Acetonitrile and water with 0.1% trifluoroacetic acid for HPLC reference standards, matching the mobile phase.

Brief sonication and gentle warming speed dissolution. Shaking is avoided because peptides unfold and aggregate at the air-water interface.

Reconstituting a lyophilised peptide

The sealed vial is left to reach room temperature before it is opened, so that water vapour does not condense on the cold powder. The chosen volume of bacteriostatic water is added slowly down the inside wall of the vial with a syringe, and the vial is swirled until the solid is gone. Where solubility is uncertain, a small amount is tested first.

Concentration is the label mass divided by the volume added: 5 mg in 1 mL gives 5 mg/mL. Dividing by the molecular weight converts it to molarity, so 5 mg/mL of a 3,000 Da peptide is about 1.67 mM. The reconstitution calculator performs this arithmetic for any label mass and volume. When precision matters, the HPLC purity figure on the Certificate of Analysis and the net peptide content, where reported, both lower the true concentration below the nominal one.

Keeping the solution intact

The lyophilised powder is kept sealed, dry and away from light, refrigerated per the product documentation. Once reconstituted, the solution is refrigerated and used within the period on the documentation. Chemical change in solution comes from hydrolysis at aspartate bonds, deamidation of asparagine, oxidation of methionine, cysteine and tryptophan, and any protease carried in from a non-sterile source. Physical loss comes from adsorption to glass and untreated polypropylene at low micromolar concentration, limited by low-binding tubes. Single-use aliquots limit freeze-thaw cycles, each of which concentrates the peptide in the last liquid to freeze and can trigger aggregation. NuVion peptides are characterised by RP-HPLC for purity and mass spectrometry for identity, and the certificate for a tested batch is available in the Certificates of Analysis library.

Frequently asked questions

Why does a peptide fail to dissolve in water?

Usually because the working pH is close to its isoelectric point, or because more than about half its residues are hydrophobic. Dilute acid or base moves the pH away from the pI; a small volume of DMSO before the water addresses the second.

How is the concentration of a reconstituted peptide calculated?

Label mass divided by the volume of solvent added gives mg/mL, and dividing by the molecular weight gives molarity. The reconstitution calculator does the conversion.

Can a reconstituted peptide solution be frozen?

Solutions are refrigerated and used within the period on the product documentation. Where freezing is unavoidable, single-use aliquots limit freeze-thaw cycles, the main cause of aggregation in frozen peptide solutions.

Are research peptides therapeutic goods in Australia?

No. NuVion Health supplies them as laboratory chemicals for in vitro research use only, and they are not sold or presented as therapeutic goods. The notice below sets out their regulatory position.

Research use only. This product is a laboratory chemical supplied for in vitro research. It is not included in the Australian Register of Therapeutic Goods and has not been assessed by the Therapeutic Goods Administration for quality, safety or efficacy. It is not for human or veterinary use, and nothing on this page is a representation about therapeutic use.